Pharmaceutical Excipients Market

Chapter: 1 INTRODUCTION

1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology

1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2020

2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Government regulations

3.3.1 US-FDA perspective
3.3.2 EU EMEA perspective
3.3.3 Japan MHW perspective

3.4 Nanotechnology in excipient
3.5 Emerging role of excipients in the pharmaceutical industry
3.6 Porters five force analysis

3.6.1 Limited suppliers increase bargaining power
3.6.2 Lesser bargaining power of buyers due to intense competition
3.6.3 Lesser hazard from substitutes due to high fixed cost
3.6.4 Lesser threats from new entrants due to high capital investment
3.6.5 Superficial competition due to lesser global players

3.7 Value chain analysis
3.8 Patent analysis
3.9 Clinical trials

3.9.1 A study of insulin lispro with biochaperone excipients in healthy participants
3.9.2 Understanding typhoid disease after vaccination
3.9.3 Clinical trial no. 2 effect on acetaminophen metabolism by liquid formulations
3.9.4 Class 3 biowaivers
3.9.5 Phase 1 Norwalk vaccine study

3.10 Market dynamics

3.10.1 Drivers

3.10.1.1 Positive momentum of pharmaceutical industries
3.10.1.2 Impact of new excipients on the pharmaceutical industry
3.10.1.3 Diversified geographic market that reduces earnings

3.10.2 Restraints

3.10.2.1 Supply chain issues
3.10.2.2 SegregatedPHARMACEUTICAL EXCIPIENTS market that reduces earnings
3.10.2.3 Higher production cost
3.10.2.4 Stringent government regulations
3.10.2.5 Declining R&D investment

3.10.3 Opportunities

3.10.3.1 Opportunities in developing economies
3.10.3.2 New product development

Chapter 4 PHARMACEUTICAL EXCIPIENTS MARKET BY TYPE, 2014-2020

4.1 Overview

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast

4.2 Inorganic Chemicals

4.2.1 Market size and forecast
4.2.2 Calcium Phosphates

4.2.2.1 Market size and forecast

4.2.3 Calcium Carbonate

4.2.3.1 Market size and forecast

4.2.4 Calcium Sulfate

4.2.4.1 Market size and forecast

4.2.5 Halites

4.2.5.1 Market size and forecast

4.2.6 Metallic Oxides

4.2.6.1 Market size and forecast

4.2.7 Others

4.2.7.1 Market size and forecast

4.3 Organic chemicals

4.3.1 Market size and forecast
4.3.2 Carbohydrates

4.3.2.1 Market size and foreast
4.3.2.2 Sugars

4.3.2.2.1 MARKET SIZE AND FORECAST

4.3.2.3 Starch

4.3.2.3.1 MARKET SIZE AND FORECAST

4.3.2.4 Cellulose

4.3.2.4.1 MARKET SIZE AND FORECAST

4.3.3 Petrochemicals

4.3.3.1 Market size and forecast
4.3.3.2 Glycols (Alcohol)

4.3.3.2.1 MARKET SIZE AND FORECAST

4.3.3.3 Povidones Polymers

4.3.3.3.1 MARKET SIZE AND FORECAST

4.3.3.4 Mineral Hydrocarbons

4.3.3.4.1 MARKET SIZE AND FORECAST

4.3.3.5 Oleochemicals

4.3.3.5.1 MARKET SIZE AND FORECAST

4.3.3.6 Gelatin (Proteins)

4.3.3.6.1 MARKET SIZE AND FORECAST

Chapter 5 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2014-2020

5.1 Overview

5.1.1 Key market trends
5.1.2 Key growth factors and opportunities
5.1.3 Market size and forecast

5.2 Fillers & Diluents

5.2.1 Market size and forecast

5.3 Suspension & viscosity agents

5.3.1 Market size and forecast

5.4 Binders

5.4.1 Market size and forecast

5.5 Coatings

5.5.1 Market size and forecast

5.6 Flavoring agents

5.6.1 Market size and forecast

5.7 Disintegrants

5.7.1 Market size and forecast

5.8 Colorants

5.8.1 Market size and forecast

5.9 Others

5.9.1 Lubricants & Glidants

5.9.1.1 Role of lubricants

5.9.2 Preservatives
5.9.3 Market size and forecast

Chapter 6 PHARMACEUTICAL EXCIPIENTS MARKET BY GEOGRAPHY, 2014-2020

6.1 Overview
6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

Chapter 7 COMPANY PROFILES

7.1 Ashland Inc.

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Key strategies of Ashland Inc.

7.1.4.1 Primary Strategies: Product Launch
7.1.4.2 Secondary Strategies: Agreement

7.1.5 SWOT analysis of Ashland Inc.

7.2 Associated British Food Plc

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Key strategies of Associated British Food Plc

7.2.4.1 Primary Strategies: Product Launch
7.2.4.2 Secondary Strategies: Alliance

7.2.5 SWOT analysis of Associated British Food Plc

7.3 AkzoNobel

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Key strategies of AkzoNobel

7.3.3.1 Primary Strategies: Expansion
7.3.3.2 Secondary Strategies: acquisition

7.3.4 SWOT analysis of AkzoNobel

7.4 Evonik

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Key strategies of Evonik

7.4.4.1 Primary Strategies: Investments
7.4.4.2 Secondary Strategies: Expansion

7.4.5 SWOT analysis of Evonik

7.5 J.M. Huber Corporation

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Key strategies of J.M. Huber Corporation

7.5.3.1 Primary Strategies: expansion

7.5.4 SWOT analysis of J.M. Huber Corporation

7.6 Archer Daniels Midland

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Key strategies of Archer Daniels Midland

7.6.3.1 Primary Strategies: Product launch
7.6.3.2 Secondary Strategies: collaborations

7.6.4 SWOT analysis of Archer Daniels Midland

7.7 BASF

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Key strategies of BASF

7.7.3.1 Primary Strategies: Innovation
7.7.3.2 Secondary Strategies: acquisition

7.7.4 SWOT analysis of BASF

7.8 Dow Chemical Corporation

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Key strategies of Dow Chemical Corporation

7.8.4.1 Primary Strategies: Collboration
7.8.4.2 Secondary Strategies: new product launches

7.8.5 SWOT analysis of Dow Chemical Corporation

7.9 Merck Millipore

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Business performance
7.9.4 Key strategies of Merck Millipore

7.9.4.1 Primary Strategies: Product Launch

7.9.5 SWOT analysis of Merck Millipore

7.10 Croda International plc

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Business performance
7.10.4 Key strategies of Croda International plc.

7.10.4.1 Primary Strategies: approval and expansion

7.10.5 SWOT analysis of Croda International plc.

List of Figures

FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2020-2025)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020-2025)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 WORLD PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION
FIG. 5 TOP INVESTMENT POCKETS IN THE WORLD PHARMACEUTICAL EXCIPIENTS MARKET, 2014
FIG. 6 DISTRIBUTION OF TOP WINNING STRATEGIES
FIG. 7 PORTERS FIVE FORCE ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET
FIG. 8 VALUE CHAIN ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET
FIG. 9 PATENT ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET FROM 2014-2015
FIG. 10 TOP FACTORS IMPACTING WORLD PHARMACEUTICAL EXCIPIENTS MARKET, 2014-2020
FIG. 11 KEY FINANCIALS OF ASHLAND INC. BY GEOGRAPHY (2014)
FIG. 12 KEY FINANCIALS OF ASHLAND INC. BY REPORTABLE SEGMENTS (2014)
FIG. 13 SWOT ANALYSIS OF ASHLAND INC.
FIG. 14 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY GEOGRAPHY (2015)
FIG. 15 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY REPORTABLE SEGMENTS (2014)
FIG. 16 SWOT ANALYSIS OF ASSOCIATED BRITISH FOOD PLC
FIG. 17 KEY FINANCIALS OF AKZONOBEL BY GEOGRAPHY (2014)
FIG. 18 KEY FINANCIALS OF AKZONOBEL BY SEGMENTS (2014)
FIG. 19 SWOT ANALYSIS OF AKZONOBEL
FIG. 20 KEY FINANCIALS OF EVONIK BY BUSINESSES (2014)
FIG. 21 KEY FINANCIALS OF EVONIK BY SEGMENTS (2014)
FIG. 22 SWOT ANALYSIS OF EVONIK
FIG. 23 SWOT ANALYSIS OF J.M. HUBER CORPORATION
FIG. 24 KEY FINANCIALS OF ARCHER DANIELS MIDLAND BY BUSINESSES (2014)
FIG. 25 SWOT ANALYSIS OF ARCHER DANIELS MIDLAND
FIG. 26 KEY FINANCIALS OF BASF BY GEOGRAPHY (2014)
FIG. 27 KEY FINANCIAL OF BASF BY SALES BY REPORTABLE SEGMENTS (2014)
FIG. 28 SWOT ANALYSIS OF BASF
FIG. 29 KEY FINANCIALS OF DOW CHEMICAL CORPORATION BY GEOGRAPHY (2014)
FIG. 30 KEY FINANCIAL OF DOW CHEMICAL CORPORATION BY REPORTABLE SEGMENTS (2014)
FIG. 31 SWOT ANALYSIS OF DOW CHEMICAL CORPORATION
FIG. 32 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHY (2014)
FIG. 33 FINANCIAL REVENUES OF MERCK MILLIPORE BY BUSINESS SEGMENT (2014)
FIG. 34 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 35 FINANCIAL REVENUES OF CRODA BY GEOGRAPHY (2014)
FIG. 36 FINANCIAL REVENUES OF CRODA BY BUSINESS SEGMENT (2014)
FIG. 37 SWOT ANALYSIS OF CRODA

List of Tables

TABLE 1 WORLD PHARMACEUTICAL EXCIPIENT BASE CASE SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 2 WORLD PHARMACEUTICAL EXCIPIENT BASE CASE SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 3 WORLD PHARMACEUTICAL EXCIPIENT RAPID GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 4 WORLD PHARMACEUTICAL EXCIPIENT RAPID GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 5 WORLD PHARMACEUTICAL EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 6 WORLD PHARMACEUTICAL EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 7 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY TYPE, 2014-2020 (TONNES)
TABLE 8 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020 ($MILLION)
TABLE 9 WORLD INORGANIC CHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 10 WORLD CALCIUM PHOSPHATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 11 WORLD CALCIUM CARBONATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 12 WORLD CALCIUM SULFATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 13 WORLD HALITES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 14 WORLD METALLIC OXIDES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 15 WORLD OTHERS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 16 WORLD ORGANIC CHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 17 WORLD CARBOHYDRATES EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 18 WORLD CARBOHYDRATES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 19 WORLD SUGARS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 20 WORLD SUGARS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 21 WORLD CELLULOSE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 22 WORLD PETROCHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 23 WORLD PETROCHEMICAL EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 24 WORLD GLYCOLS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 25 FEATURES AND BENEFITS OF POVIDONES POLYMERS
TABLE 26 WORLD POVIDONE POLYMERS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 27 WORLD MINERAL HYDROCARBONS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 28 WORLD OLEOCHEMICALS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 29 WORLD GELATIN EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 30 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY FUNCTION, 2014-2020, (TONNES)
TABLE 31 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 32 WORLD FILLERS& DILUENTS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 33 WORLD SUSPENSION & VISCOSITY AGENTS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 34 TYPES OF BINDERS USED AS EXCIPIENTS
TABLE 35 COMMON TYPE OF BINDERS USED IN THE MARKET
TABLE 36 WORLD BINDERS EXCIPIENTMARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 37 WORLD COATINGS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 38 WORLD FLAVORING AGENTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 49 WORLD DISINTEGRANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 40 WORLD COLORANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 41 WORLD OTHERS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 42 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY GEOGRAPHY, 2014-2020, (TONNES)
TABLE 43 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONS, 2014-2020, ($MILLION)
TABLE 45 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 46 ASIA PACIFIC EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 47 LAMEA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 48 ASHLAND INC. COMPANY SNAPSHOT
TABLE 59 ASSOCIATED BRITISH FOOD PLC COMPANY SNAPSHOT
TABLE 50 AKZONOBEL COMPANY SNAPSHOT
TABLE 51 EVONIK COMPANY SNAPSHOT
TABLE 52 J.M. HUBER CORPORATION COMPANY SNAPSHOT
TABLE 53 ARCHER DANIELS MIDLAND COMPANY SNAPSHOT
TABLE 54 BASF COMPANY SNAPSHOT
TABLE 55 DOW CHEMICAL CORPORATION COMPANY SNAPSHOT
TABLE 56 SNAPSHOT OF MERCK MILLIPORE
TABLE 57 SNAPSHOT OF CRODA